In this week's C&EN, this news from Rick Mullin:
PharmaBlock, a pharmaceutical research and manufacturing services firm, has opened an R&D site in West Chester, Pennsylvania. With 2,800 m2 of laboratory space, the facility includes process and analytical labs, as well as manufacturing suites with flow chemistry, micropacked bed hydrogenation, and solid-state chemistry capabilities. PharmaBlock says the site will enhance its production of clinical- stage active pharmaceutical ingredients (APIs) for the US market. The company plans to add reactors ranging from 500 to 2,000 L for API production in West Chester next year.
I feel like there is more and more API manufacturing than one would expect being built in the United States these days... (I guess the real question is how many cubic meters are being installed elsewhere at the same time?) Well, there's at least a few research and QC positions...
No comments:
Post a Comment
looks like Blogger doesn't work with anonymous comments from Chrome browsers at the moment - works in Microsoft Edge, or from Chrome with a Blogger account - sorry! CJ 3/21/20